Background Analysis: US FDA Advisory Committee Seeks Input on Safety Data from the Cardiovascular Outcomes Trial for Pfizer’s Celebrex Report
Background Analysis: US FDA Advisory Committee Seeks Input on Safety Data from the Cardiovascular Outcomes Trial for Pfizer’s Celebrex Report